Insider Transactions in Q4 2024 at Vir Biotechnology, Inc. (VIR)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 15
2024
|
Jason O'Byrne EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+50.0%
|
-
|
|
Nov 06
2024
|
Vanina De Verneuil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
4,397
-7.16%
|
$43,970
$10.11 P/Share
|
|
Nov 05
2024
|
Vanina De Verneuil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
2,347
-3.68%
|
$21,123
$9.47 P/Share
|
|
Nov 01
2024
|
Vanina De Verneuil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
1,403
-2.15%
|
$9,821
$7.2 P/Share
|
|
Oct 23
2024
|
George A Scangos Director |
SELL
Other acquisition or disposition
|
Indirect |
1,196,540
-34.19%
|
-
|
|
Oct 23
2024
|
George A Scangos Director |
BUY
Other acquisition or disposition
|
Indirect |
598,270
+50.0%
|
-
|
|
Oct 23
2024
|
George A Scangos Director |
BUY
Other acquisition or disposition
|
Direct |
598,270
+45.41%
|
-
|